People News

Share this article:

Hillis-Eden Pharmaceuticals, a manufacturer focused on small molecule compounds based on endogenous adrenal steroid hormones, announced the promotion of James Frincke to president and CEO. Frincke, previously chief scientific officer, was also elected to the company's board of directors. Hollis-Eden Pharmaceuticals is based in San Diego, CA.


Par Pharmaceuticals elected Thomas Rice to its board of directors. Rice was also appointed to the audit committee and nominating-corporate governance committee. Rice is a principal and co-founder of Columbia Investments, and was formerly CEO at Andrx Corporation while it was being sold to Watson Pharmaceuticals.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media